OXFORD, U.K.--Computer-aided molecular design software vendor Oxford Molecular here announced March 31 that after five unprofitable years, in 1997 it achieved an overall pretax profit of £256,000 for the year. CEO Tony Marchington attributed increased sales to successful cheminformatics and bioinformatics businesses where Oxford's Omiga and RS3 products benefitted from strong customer demand. Oxford's June 1997 acquisition of two profitable firms, Genetics Computer Group and MLR Automation, further strengthened performance, Marchington said.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.